Molnupiravir

Status:
Red
Decision Date:
December 2021
 

Comments

RED - approved for use via the COVID Medicines Delivery Unit, in 'highest' risk non-hospitalised patients with COVID-19 in accordance with current NHSE commissioning policy.

Molnupiravir is restricted for supply via secondary care (CMDU). Further information on the oral antiviral can be found here.


Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app